EUVIMEDEUVIMED entdecken
Crossref

A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod

Ting Du, Liming He, Jie Wang, Chunyan Pan, Yunkun Xing, Wei Zhao, Chunli Yang, Yingchu Dong, Shuai Yang, Min Shen, Xu Jia, Maling Gou

Chinese Chemical Letters · 2026-05 · 112938

DOI: 10.1016/j.cclet.2026.112938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Ting Du und 11 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Chengdu Medical College, National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Chengdu Medical College
  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Du, T., He, L., Wang, J., Pan, C., Xing, Y., Zhao, W., Yang, C., Dong, Y., Yang, S., Shen, M., Jia, X., & Gou, M. (2026). A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod. Chinese Chemical Letters, 112938. https://doi.org/10.1016/j.cclet.2026.112938

Vancouver

Du T, He L, Wang J, Pan C, Xing Y, Zhao W, et al. A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod. Chinese Chemical Letters. 2026:112938. doi:10.1016/j.cclet.2026.112938

BibTeX
@article{Du2026,
  author = {Du, Ting and He, Liming and Wang, Jie and Pan, Chunyan and Xing, Yunkun and Zhao, Wei and Yang, Chunli and Dong, Yingchu and Yang, Shuai and Shen, Min and Jia, Xu and Gou, Maling},
  title = {A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod},
  journal = {Chinese Chemical Letters},
  year = {2026},
  pages = {112938},
  doi = {10.1016/j.cclet.2026.112938}
}
Kostenlos starten →